Your Messages Inbox
Your Article Summary
See Latest ArticlesInspire Announces Closing of $115 Million Public Offering
Inspire, 08/11/09
Inspire Pharmaceuticals, Inc. announced the closing of its previously announced public offering of 22,222,223 shares of its common stock. The Company also announced that the underwriter exercised in full its over–allotment option to purchase an additional 3,333,332 shares, bringing the total shares sold to 25,555,555 at a price of $4.50 per share for gross proceeds of $115 million. Net proceeds were $109 million, after deducting underwriting discounts and estimated offering expenses.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09
Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Taro Pharmaceuticals USA, 12/03/09
IMS Predicts 4% to 6% Global Pharma Market Growth Next Year
U.S. Pharmacist, 12/02/09
Article Search
Sponsor